Nephrocare Health Services share price
NSE: NEPHROPLUSBSE: 544647Healthcare ServicesSmall Cap
Nephrocare Health Services Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2025 · Issue price ₹460
Last close ₹628.40down ₹6.20 (0.98%)BSE ₹628.00
Share price at the NSE close on 28 Oct 2026. Previous close ₹634.60.
28 Oct: open ₹634.60, high ₹637.90, low ₹625.45
Range of traded prices from listing on 17 Dec 2025 to 28 Oct 2026
₹446.00Low, 19 Dec 2025₹781.50High, 11 Sep 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,319 Cr739th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.66
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Dec 2025
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 59,025
Results
Consolidated; ₹ crore.Nephrocare Health Services quarterly results
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹282 Crup 6.08%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹32 Crup 5.28%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 11.3%
Revenue by quarter
Peak revenue ₹282 Cr, quarter to Jun 2026; lowest ₹260 Cr, quarter to Dec 2025
Net profit by quarter, a loss in red
| ₹ crore | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Revenue | 260 | 266 | 282 |
| Net profit | 32 | 30 | 32 |
| Net margin | 12.4% | 11.4% | 11.3% |
Consolidated. The 3 quarters from Dec 2025, the first on record. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026
- Revenue
- ₹999 Cr
- Net profit
- ₹77 Cr
- Net margin
- 7.7%
| ₹ crore | Mar 2026 |
|---|---|
| Revenue | 999 |
| Net profit | 77 |
| Net margin | 7.7% |
Consolidated. Years to March. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Healthcare services, which carries all its revenue.
Mutual fund holdings
26 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 3 of the 7 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.All 26 funds holding Nephrocare Health Services
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 12
- Bought againBought again. Funds that held it at the month's end, had not held it the month before, and held it in an earlier month.
- 1
- AddedAdded. Funds that held more shares than at the end of the month before.
- 6
- CutCut. Funds that held fewer shares than at the end of the month before.
- 1
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 6
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end. Sold out in the glossary
- 1
| Fund | |||
|---|---|---|---|
 SBI Healthcare Opportunities FundSBI Mutual Fund | 10,00,000 | 1.12% | ₹66.0 Cr |
 DSP Healthcare FundDSP Mutual Fund | 6,34,983 | 1.12% | ₹41.9 Cr |
 Helios Small Cap FundHelios Mutual Fund | 3,81,334 | 1.33% | ₹25.2 Cr |
 Bandhan Innovation FundBandhan Mutual Fund | 3,64,005 | 0.78% | ₹24.0 Cr |
 LIC MF Infrastructure FundLIC Mutual Fund | 3,52,000 | 2.01% | ₹23.2 Cr |
| Bandhan Small Cap FundBandhan Mutual Fund | 2,81,637 | 0.05% | ₹18.6 Cr |
| LIC MF Multi Asset Allocation FundLIC Mutual Fund | 2,01,000 | 1.37% | ₹13.3 Cr |
 ICICI Prudential Retirement Fund - Hybrid AggressiveICICI Prudential Mutual Fund | 1,89,672 | 0.99% | ₹12.5 Cr |
| LIC MF Value FundLIC Mutual Fund | 1,60,000 | 3.14% | ₹10.6 Cr |
| Bandhan Contra FundBandhan Mutual Fund | 1,23,565 | 0.48% | ₹8.15 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Promoter and insider buying and selling
Trades made since 28 Oct 2025.Nephrocare Health Services insider trading
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade
- Others: no market trade · 3 pledge filings of unclear kind
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Nephrocare Health Services competitors and peers
Healthcare Service Provider, 37 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Nephrocare Health Services in market cap.Healthcare companies
Nephrocare Health Services is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Dr. Lal Path LabsLALPATHLAB | 32,266 | 59.54 | 12.86 | +14.3% | +5.6% | 23.2% | 26.2% | 0.83% |
 Vijaya Diagnostic CentreVIJAYA | 14,861 | 79.26 | 15.53 | +20.2% | +24.9% | 21.4% | 27.8% | 0.14% |
 Metropolis HealthcareMETROPOLIS | 11,435 | 56.71 | 7.56 | +21.8% | +32.6% | 14.2% | 18.6% | 0.36% |
 Thyrocare TechnologiesTHYROCARE | 7,871 | 44.64 | 13.44 | +21.1% | +65.7% | 31.1% | 37.9% | 1.42% |
 Suraksha DiagnosticSURAKSHA | 1,623 | 45.35 | 6.63 | +23.3% | +8.1% | 15.7% | 24.0% | 0.16% |
 Krsnaa DiagnosticsKRSNAA | 1,610 | 16.52 | 1.64 | +10.2% | +21.5% | 10.5% | 8.0% | 0.40% |
 3B Blackbio Dx3BBLACKBIO | 1,170 | 21.07 | 3.61 | +54.3% | +13.2% | 18.7% | 14.1% | 0.37% |
 One Global Service ProviderONEGLOBAL | 918 | 12.41 | 6.50 | +161.6% | +178.3% | 69.4% | 69.2% | 0.21% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Nephrocare Health Services announcements
Oct 2026
27 Oct · Business
21 Oct · Analysts
12 Oct · Board meeting
Sep 2026
22 Sep · Analysts
18 Sep · Rating
Nephrocare Health Services share price by year
Each calendar year to 2025.Nephrocare Health Services share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 468.70 | – | 476.20 | 449.15 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 17 Dec 2025.
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 27 Oct 2026 | 608.00 | 639.60 | 603.25 | 634.60 | 629.53 | 1,66,220 | 51.2% |
| 26 Oct 2026 | 597.00 | 609.60 | 589.50 | 607.40 | 602.65 | 1,19,042 | 46.0% |
| 23 Oct 2026 | 604.00 | 604.00 | 580.20 | 596.45 | 591.29 | 1,48,080 | 43.1% |
| 22 Oct 2026 | 602.00 | 607.25 | 595.00 | 602.40 | 601.77 | 1,22,221 | 45.8% |
| 21 Oct 2026 | 607.00 | 615.20 | 602.80 | 608.90 | 608.75 | 1,08,595 | 54.2% |
| 19 Oct 2026 | 612.00 | 618.80 | 603.60 | 611.55 | 609.86 | 1,52,507 | 56.0% |
| 16 Oct 2026 | 611.65 | 619.40 | 609.25 | 614.35 | 615.18 | 1,35,447 | 59.2% |
| 15 Oct 2026 | 619.00 | 622.65 | 609.00 | 611.65 | 614.99 | 1,61,338 | 55.3% |
| 14 Oct 2026 | 621.50 | 623.45 | 608.40 | 617.15 | 615.77 | 1,34,499 | 52.2% |
Prices in ₹ per share as traded, not adjusted.
Company details
- NSE symbol
- NEPHROPLUS
- BSE code
- 544647
- ISIN
- INE428V01029
- Industry
- Healthcare Services
- Website
- www.nephroplus.com
- CIN
- L85100TG2009PLC066359
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2009
- Registered office
- D Block, iLabs Centre, 5th Floor, Plot 18, Software Units Layout, Survey No. 64, Madhapur, Shaikpet, Hyderabad 500081, Telangana
- Share registrar
- KFin Technologies Ltd
- Keeps the register of shareholders and handles transfers and dividend payments